Clinical Trial Update: Dose Response of Fractional Exhaled Nitric Oxide (FeNO) to Inhaled Steroids in Mild-to-moderate Asthma [Phase 4]

View source ↗

Summary

Clinical trial update reporting dose response of fractional exhaled nitric oxide to inhaled steroids in mild-to-moderate asthma (Phase 4).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Snippet

Sponsor: University of Dundee | Conditions: Asthma | Phase 4 | Status: COMPLETED